Nova Patents
ATE218344T1

Ranolazine and related piperazines for protecting skeletal muscles

Abstract

Piperazine derivatives, particularly ranolazine, are useful for treatment of tissues experiencing a physical or chemical insult, and specifically for treating shock conditions.

Term

Term ended

Projected expiry passed 21 June 2010, 16.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

40 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
37043589United States of AmericaA

Members40

Family members, oldest first
DocumentOfficeKind
CA2019580A1CanadaA1
IE902250LIrelandL
AU5761890AAustraliaA
EP0407780A2European Patent Office (EPO)A2
IE902250A1IrelandA1
JPH0348672AJapanA
EP0407780A3European Patent Office (EPO)A3
ZA904842BSouth AfricaB
AU633589B2AustraliaB2
US5506229AUnited States of AmericaA
EP0714660A1European Patent Office (EPO)A1
EP0719558A1European Patent Office (EPO)A1
EP0407780B1European Patent Office (EPO)B1
AT142497TAustriaT
ATE142497T1AustriaT1
DK0407780T3DenmarkT3
DE69028457D1GermanyD1
ES2091211T3SpainT3
GR3020976T3GreeceT3
NZ234184ANew ZealandA
DE69028457T2GermanyT2
NZ247044ANew ZealandA
IE80710B1IrelandB1
US5906988AUnited States of AmericaA
JP3232085B2JapanB2
EP0719558B1European Patent Office (EPO)B1
AT218344TAustriaT
ATE218344T1This recordAustriaT1
DE69033967D1GermanyD1
EP0714660B1European Patent Office (EPO)B1
AT223218TAustriaT
ATE223218T1AustriaT1
DK0714660T3DenmarkT3
DK0719558T3DenmarkT3
DE69034000D1GermanyD1
ES2177601T3SpainT3
DE69033967T2GermanyT2
ES2182863T3SpainT3
DE69034000T2GermanyT2
CA2019580CCanadaC